FDA Advisory Committee to Review Peptide Regulations in the U.S.
The U.S. Food and Drug Administration's Pharmacy Compounding Advisory Committee is set to meet to discuss the regulation of certain peptides, which are popular in wellness circles for their purported health benefits. The committee will consider whether compounding pharmacies should be allowed to dispense these peptides, which are not currently FDA-approved. The meeting is significant as it could determine the future accessibility of these substances, which are often used for muscle recovery, inflammation reduction, and overall health improvement. The committee's recommendations, while advisory, could influence the FDA's regulatory approach to these compounds. 
